PUBLISHER: TechNavio | PRODUCT CODE: 1911187
PUBLISHER: TechNavio | PRODUCT CODE: 1911187
The global antiemetic drug market is forecasted to grow by USD 1914.5 mn during 2024-2029, accelerating at a CAGR of 6.8% during the forecast period. The report on the global antiemetic drug market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by rising geriatric population globally, growing prevalence of nausea and vomiting, increasing healthcare expenditure.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market size data, segment with regional analysis and vendor landscape in addition to an analysis of the key companies. Reports have historic and forecast data.
| Market Scope | |
|---|---|
| Base Year | 2025 |
| End Year | 2029 |
| Series Year | 2025-2029 |
| Growth Momentum | Accelerate |
| YOY 2025 | 6% |
| CAGR | 6.8% |
| Incremental Value | $1914.5 mn |
Technavio's global antiemetic drug market is segmented as below:
By Drug Class
By Application
By Route Of Administration
Geography
This study identifies the integration of digital health solutions in antiemetic drug management as one of the prime reasons driving the global antiemetic drug market growth during the next few years. Also, growing number of recent developments related to antiemetic drugs and rising demand for antiemetic drugs in emerging economies will lead to sizable demand in the market.
The report on the global antiemetic drug market covers the following areas:
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading global antiemetic drug market vendors that include Algen Healthcare Ltd., Bristol Laboratories Ltd., Cadila Pharmaceuticals Ltd., Cipla Inc., Eagle Pharmaceuticals Inc., Fresenius SE and Co. KGaA, GlaxoSmithKline Plc, Helsinn Healthcare SA, Heron Therapeutics Inc., Lupin Ltd., Merck and Co. Inc., Novartis AG, Otsuka Holdings Co. Ltd., Pfizer Inc., RedHill Biopharma Ltd., Sanofi SA, Takeda Pharmaceutical Ltd., Teva Pharmaceutical Ltd., Viatris Inc.. Also, the global antiemetic drug market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive primary and secondary research. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast accurate market growth.